UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 30

Sortiert nach

Real-world data of six patients with atypical hemolytic uremic syndrome switched to ravulizumab

Pediatric nephrology (Berlin, West), 2021-10, Vol.36 (10), p.3281-3282

2021

Volltextzugriff (PDF)

5/m, geschwollene Augen, Abgeschlagenheit: Vorbereitung auf die Facharztprüfung: Fall 20

Monatsschrift Kinderheilkunde, 2021-12, Vol.169 (Suppl 5), p.307-311

Ehren, Rasmus

2021

Volltextzugriff (PDF)

Effect of mycophenolic acid in experimental, nontransplant glomerular diseases: new mechanisms beyond immune cells

Pediatric nephrology (Berlin, West), 2017-08, Vol.32 (8), p.1315-1322

2017

Volltextzugriff (PDF)

The impact of a needs-oriented dental prophylaxis program on bacteremia after toothbrushing and systemic inflammation in children, adolescents, and young adults with chronic kidney disease

Pediatric nephrology (Berlin, West), 2022-02, Vol.37 (2), p.403-414

2022

Volltextzugriff (PDF)

Repetitive administration of rituximab can achieve and maintain clinical remission in patients with MCD or FSGS

Scientific reports, 2023-04, Vol.13 (1), p.6980-6980, Article 6980

2023

Volltextzugriff (PDF)

A multicenter retrospective study of calcineurin inhibitors in nephrotic syndrome secondary to podocyte gene variants

Kidney international, 2023-05, Vol.103 (5), p.962-972

2023

Volltextzugriff (PDF)

The role of the immune system in idiopathic nephrotic syndrome

Molecular and cellular pediatrics, 2021-11, Vol.8 (1), p.18-18, Article 18

2021

Volltextzugriff (PDF)

Clinical practice recommendations for recurrence of focal and segmental glomerulosclerosis/steroid‐resistant nephrotic syndrome

Pediatric transplantation, 2021-05, Vol.25 (3), p.e13955-n/a

2021

Volltextzugriff (PDF)

Commentary on “Pediatric Idiopathic Steroid-sensitive Nephrotic Syndrome Diagnosis and Therapy - Short version of the updated German Best Practice Guideline (S2e)”

Pediatric nephrology (Berlin, West), 2021-10, Vol.36 (10), p.2961-2966

2021

Volltextzugriff (PDF)

Pharmacodynamic Monitoring of Mycophenolic Acid Therapy: Improved Liquid Chromatography-Tandem Mass Spectrometry Method for Measuring Inosin-5'-Monophosphate Dehydrogenase Activity

Therapeutic drug monitoring, 2020-04, Vol.42 (2), p.282

2020

Volltextzugriff (PDF)

Precise variant interpretation, phenotype ascertainment, and genotype–phenotype correlation of children in the EARLY PRO‐TECT Alport trial

Clinical genetics, 2021-01, Vol.99 (1), p.143-156

2021

Volltextzugriff (PDF)

FP775CHILDREN WITH HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA (FH) ON LIPOPROTEIN APHERESIS − A FOUR YEAR FOLLOW−UP

Nephrology, dialysis, transplantation, 2018-05, Vol.33 (suppl_1), p.i306-i307

2018

Volltextzugriff (PDF)

Inadequate Dosage of Mycophenolate Mofetil Is Likely to Yield Substandard Trial Results and Substandard Patient Care

JAMA pediatrics, 2021-08, Vol.175 (8), p.869

2021

Volltextzugriff (PDF)

A multicenter, randomized, placebo-controlled, double-blind phase 3 trial with open-arm comparison indicates safety and efficacy of nephroprotective therapy with ramipril in children with Alport’s syndrome

Kidney international, 2020-06, Vol.97 (6), p.1275-1286

2020

Volltextzugriff (PDF)

Pediatric idiopathic steroid-sensitive nephrotic syndrome: diagnosis and therapy -short version of the updated German best practice guideline

Pediatric nephrology (Berlin, West), 2021-10, Vol.36 (10), p.2971

2021

Volltextzugriff (PDF)

Therapeutic drug monitoring of mycophenolate mofetil in pediatric patients: novel techniques and current opinion

Expert opinion on drug metabolism & toxicology, 2021-02, Vol.17 (2), p.201-213

2021

Volltextzugriff (PDF)

The quest for optimal control of relapses in children with nephrotic syndrome

Kidney international, 2019-03, Vol.95 (3), p.717-717

2019

Volltextzugriff (PDF)

Peritoneal dialysis in extremely and very low-birth-weight infants

Peritoneal dialysis international, 2020-03, Vol.40 (2), p.233-236

2020

Volltextzugriff (PDF)

3670 THE ROLE OF CALCINEURIN INHIBITORS IN MONOGENIC PEDIATRIC STEROID RESISTANT NEPHROTIC SYNDROME: A RETROSPECTIVE, MULTICENTER STUDY

Nephrology, dialysis, transplantation, 2023-06, Vol.38 (Supplement_1)

2023

Volltextzugriff (PDF)

Corrigendum to “A multicenter retrospective study of calcineurin inhibitors in nephrotic syndrome secondary to podocyte gene variants.” Kidney Int. 2023;103:962–972

Kidney international, 2024-01, Vol.105 (1), p.213-214

2024

Volltextzugriff (PDF)

Mycophenolate Mofetil Therapy in Children With Idiopathic Nephrotic Syndrome: Does Therapeutic Drug Monitoring Make a Difference?

Therapeutic drug monitoring, 2016-04, Vol.38 (2), p.274

2016

Volltextzugriff (PDF)

A newly established clinical registry of minimal change disease and focal and segmental glomerulosclerosis in Germany

Nephrology, dialysis, transplantation, 2019-12, Vol.34 (12), p.1983-1986

2019

Volltextzugriff (PDF)

Discontinuation of maintenance therapy in frequently relapsing nephrotic syndrome

Clinical nephrology, 2019-01, Vol.91 (1), p.25

2019

Volltextzugriff (PDF)

Intensive oral prophylaxis does not alter the tongue microbiome in young patients with chronic kidney disease: longitudinal, randomized, controlled study

Frontiers in immunology, 2024-08, Vol.15

2024

Volltextzugriff (PDF)

Successful discontinuation of eculizumab under immunosuppressive therapy in DEAP-HUS

Pediatric nephrology (Berlin, West), 2017-06, Vol.32 (6), p.1081-1087

2017

Volltextzugriff (PDF)

1 – 25 von 30

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(28)
Mit Volltextzugriff
(24)

Publikationsform

Artikel
(30)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Real-world data of six patients with atypical hemolytic uremic syndrome switched to ravulizumab

5/m, geschwollene Augen, Abgeschlagenheit: Vorbereitung auf die Facharztprüfung: Fall 20

Effect of mycophenolic acid in experimental, nontransplant glomerular diseases: new mechanisms beyond immune cells

The impact of a needs-oriented dental prophylaxis program on bacteremia after toothbrushing and systemic inflammation in children, adolescents, and young adults with chronic kidney disease

Repetitive administration of rituximab can achieve and maintain clinical remission in patients with MCD or FSGS

A multicenter retrospective study of calcineurin inhibitors in nephrotic syndrome secondary to podocyte gene variants

The role of the immune system in idiopathic nephrotic syndrome

Clinical practice recommendations for recurrence of focal and segmental glomerulosclerosis/steroid‐resistant nephrotic syndrome

Commentary on “Pediatric Idiopathic Steroid-sensitive Nephrotic Syndrome Diagnosis and Therapy - Short version of the updated German Best Practice Guideline (S2e)”

Pharmacodynamic Monitoring of Mycophenolic Acid Therapy: Improved Liquid Chromatography-Tandem Mass Spectrometry Method for Measuring Inosin-5'-Monophosphate Dehydrogenase Activity

Precise variant interpretation, phenotype ascertainment, and genotype–phenotype correlation of children in the EARLY PRO‐TECT Alport trial

FP775CHILDREN WITH HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA (FH) ON LIPOPROTEIN APHERESIS − A FOUR YEAR FOLLOW−UP

Inadequate Dosage of Mycophenolate Mofetil Is Likely to Yield Substandard Trial Results and Substandard Patient Care

A multicenter, randomized, placebo-controlled, double-blind phase 3 trial with open-arm comparison indicates safety and efficacy of nephroprotective therapy with ramipril in children with Alport’s syndrome

Pediatric idiopathic steroid-sensitive nephrotic syndrome: diagnosis and therapy -short version of the updated German best practice guideline

Therapeutic drug monitoring of mycophenolate mofetil in pediatric patients: novel techniques and current opinion

The quest for optimal control of relapses in children with nephrotic syndrome

Peritoneal dialysis in extremely and very low-birth-weight infants

3670 THE ROLE OF CALCINEURIN INHIBITORS IN MONOGENIC PEDIATRIC STEROID RESISTANT NEPHROTIC SYNDROME: A RETROSPECTIVE, MULTICENTER STUDY

Corrigendum to “A multicenter retrospective study of calcineurin inhibitors in nephrotic syndrome secondary to podocyte gene variants.” Kidney Int. 2023;103:962–972

Mycophenolate Mofetil Therapy in Children With Idiopathic Nephrotic Syndrome: Does Therapeutic Drug Monitoring Make a Difference?

A newly established clinical registry of minimal change disease and focal and segmental glomerulosclerosis in Germany

Discontinuation of maintenance therapy in frequently relapsing nephrotic syndrome

Intensive oral prophylaxis does not alter the tongue microbiome in young patients with chronic kidney disease: longitudinal, randomized, controlled study

Successful discontinuation of eculizumab under immunosuppressive therapy in DEAP-HUS

Suchergebnisse filtern